NO124265B - - Google Patents
Download PDFInfo
- Publication number
- NO124265B NO124265B NO163009A NO16300966A NO124265B NO 124265 B NO124265 B NO 124265B NO 163009 A NO163009 A NO 163009A NO 16300966 A NO16300966 A NO 16300966A NO 124265 B NO124265 B NO 124265B
- Authority
- NO
- Norway
- Prior art keywords
- cells
- infectious hepatitis
- hepatitis virus
- virus
- live
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 claims description 49
- 241000700605 Viruses Species 0.000 claims description 43
- 208000037319 Hepatitis infectious Diseases 0.000 claims description 33
- 208000005252 hepatitis A Diseases 0.000 claims description 33
- 210000002966 serum Anatomy 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 27
- 210000001519 tissue Anatomy 0.000 claims description 22
- 229960005486 vaccine Drugs 0.000 claims description 19
- 239000012531 culture fluid Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 241000282693 Cercopithecidae Species 0.000 claims description 6
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 5
- 102000036639 antigens Human genes 0.000 claims description 5
- 108091007433 antigens Proteins 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 210000002308 embryonic cell Anatomy 0.000 claims description 4
- 239000002356 single layer Substances 0.000 claims description 4
- 108010077544 Chromatin Proteins 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 210000003483 chromatin Anatomy 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000011343 solid material Substances 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 230000002411 adverse Effects 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 25
- 239000000725 suspension Substances 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 230000002458 infectious effect Effects 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- 239000003139 biocide Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 239000012499 inoculation medium Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010014979 Epidemic typhus Diseases 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000287231 Serinus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F214/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen
- C08F214/02—Monomers containing chlorine
- C08F214/04—Monomers containing two carbon atoms
- C08F214/08—Vinylidene chloride
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S526/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S526/915—Redox catalyst
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Paints Or Removers (AREA)
- Polymerisation Methods In General (AREA)
- Paper (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH689765A CH449264A (de) | 1965-05-18 | 1965-05-18 | Verfahren zur Herstellung neuer Copolymerisate des Vinylidenchlorides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124265B true NO124265B (xx) | 1972-03-27 |
Family
ID=4316773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO163009A NO124265B (xx) | 1965-05-18 | 1966-05-13 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3449302A (xx) |
| AT (1) | AT267172B (xx) |
| BE (1) | BE681150A (xx) |
| CH (1) | CH449264A (xx) |
| DE (1) | DE1595413A1 (xx) |
| GB (1) | GB1082037A (xx) |
| NL (1) | NL6606757A (xx) |
| NO (1) | NO124265B (xx) |
| SE (1) | SE328697B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3850726A (en) * | 1969-04-28 | 1974-11-26 | Staley Mfg Co A E | Vinylidene chloride copolymer |
| US3946139A (en) * | 1974-01-17 | 1976-03-23 | W. R. Grace & Co. | Vinylidene chloride copolymer latexes |
| JPS6053055B2 (ja) * | 1980-02-15 | 1985-11-22 | 旭化成株式会社 | 塩化ビニリデン系樹脂水分散体組成 |
| US4446273A (en) * | 1981-06-03 | 1984-05-01 | The Dow Chemical Company | Aqueous dispersions of vinylidene chloride resins |
| US6312820B1 (en) | 1983-07-25 | 2001-11-06 | Henkel Corporation | Vinylidene chloride resin in autodeposition |
| US5912297A (en) * | 1983-07-25 | 1999-06-15 | Henkel Corporation | Internally stabilized vinylidene chloride resin in autodeposition |
| KR100557553B1 (ko) * | 2001-06-29 | 2006-03-03 | 주식회사 하이닉스반도체 | 포토레지스트 단량체, 그의 중합체 및 이를 함유하는포토레지스트 조성물 |
| US7165676B2 (en) * | 2002-04-19 | 2007-01-23 | Smurfit-Stone Container Enterprises, Inc. | Heat seal blister package having improved moisture vapor transmission barrier and method for forming same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE588412A (xx) * | 1959-03-13 | |||
| US3235535A (en) * | 1962-04-10 | 1966-02-15 | Union Carbide Corp | Aromatic vinyl sulfones and polymers thereof |
| US3192231A (en) * | 1962-09-19 | 1965-06-29 | American Cyanamid Co | Unsaturated substituted cyclic sulfones and process for preparing the same |
| US3310535A (en) * | 1963-06-24 | 1967-03-21 | Monsanto Co | Acrylonitrile tetrapolymers, process for preparing same and fibers thereof |
-
1965
- 1965-05-18 CH CH689765A patent/CH449264A/de unknown
-
1966
- 1966-05-03 US US547168A patent/US3449302A/en not_active Expired - Lifetime
- 1966-05-10 DE DE19661595413 patent/DE1595413A1/de active Pending
- 1966-05-10 GB GB20729/66A patent/GB1082037A/en not_active Expired
- 1966-05-13 NO NO163009A patent/NO124265B/no unknown
- 1966-05-16 SE SE06709/66A patent/SE328697B/xx unknown
- 1966-05-17 AT AT466766A patent/AT267172B/de active
- 1966-05-17 BE BE681150D patent/BE681150A/xx unknown
- 1966-05-17 NL NL6606757A patent/NL6606757A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1595413A1 (de) | 1970-03-19 |
| NL6606757A (xx) | 1966-11-21 |
| US3449302A (en) | 1969-06-10 |
| CH449264A (de) | 1967-12-31 |
| AT267172B (de) | 1968-12-10 |
| GB1082037A (en) | 1967-09-06 |
| SE328697B (xx) | 1970-09-21 |
| BE681150A (xx) | 1966-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hanafusa et al. | Analysis of the defectiveness of Rous sarcoma virus, II. Specification of RSV antigenicity by helper virus | |
| Habel | Cultivation of mumps virus in the developing chick embryo and its application to studies of immunity to mumps in man | |
| Gardner et al. | New human papovavirus (BK) isolated from urine after renal transplantation | |
| Hobson et al. | Virological studies in natural common colds in Sheffield in 1960 | |
| JP3950500B2 (ja) | 魚類用のイリドウイルス感染症ワクチンと診断剤並びにこれ等の製法 | |
| Motsumoto | Rabies virus | |
| NO124265B (xx) | ||
| Friesen et al. | Some physicochemical and immunological properties of an avian leucosis virus (RIF) | |
| NO140725B (no) | Energiabsorberende trykkavlastningsventil | |
| Bell | An introduction to general virology | |
| US3105011A (en) | Antigens and process of producing same | |
| Högman | The Principle of Mixed Agglutination Applied to Tissue Culture Systems: A Method for Study of Cell‐Bound Blood‐Group Antigens | |
| JP4944643B2 (ja) | 魚類用のイリドウイルス感染症ワクチンと診断剤並びにこれ等の製法 | |
| Deshmukh et al. | Avian reoviruses. II. Physicochemical characterization and classification | |
| CN106310247A (zh) | 小鹅瘟灭活疫苗的制备方法及其制备的灭活疫苗 | |
| US3143470A (en) | Rabies virus propagation in embryonic cells maintained in a medium containing pancreatic digest of casein | |
| Musser et al. | Measles virus growth in canine renal cell cultures | |
| Deinhardt et al. | Viral hepatitis in non-human primates. | |
| Chomiak et al. | Tissue culture and chicken embryo techniques for infectious laryngotracheitis virus studies | |
| Liebhaber et al. | STUDIES OF A MYXOVIRUS RECOVERED FROM PATIENTS WITH INFECTIOUS HEPATITIS: I. ISOLATION AND CHARACTERIZATION | |
| Malloch et al. | Studies on the susceptibility of Rickettsia burneti to chemical disinfectants, and on techniques for detecting small numbers of viable organisms | |
| JP2681063B2 (ja) | 腎症候性出血熱ウイルス抗原の製造方法、及び該抗原を含有するワクチン並びに腎症候性出血熱診断剤 | |
| Davis | The use of phenolized allantoic fluid antigen in the complement fixation test for psittacosis | |
| Tanabe et al. | Effect of disinfectants on variola virus in cell culture | |
| Williamson et al. | Mechanism of the teratogenic action of Newcastle disease virus in the chick embryo |